WO2014068587A3 - Procédé amélioré de synthèse du dabigatran et de ses intermédiaires - Google Patents
Procédé amélioré de synthèse du dabigatran et de ses intermédiaires Download PDFInfo
- Publication number
- WO2014068587A3 WO2014068587A3 PCT/IN2013/000652 IN2013000652W WO2014068587A3 WO 2014068587 A3 WO2014068587 A3 WO 2014068587A3 IN 2013000652 W IN2013000652 W IN 2013000652W WO 2014068587 A3 WO2014068587 A3 WO 2014068587A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- synthesis
- improved process
- intermediates
- dabigatran
- formula
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La présente invention concerne un procédé amélioré de préparation du dabigatran étexilate (formule I), un sel pharmaceutiquement acceptable pour le traitement des thromboses, des maladies cardiovasculaires, etc., ainsi que des intermédiaires intervenant dans la synthèse. [Formule à insérer ici]
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14/438,995 US9533971B2 (en) | 2012-10-29 | 2013-10-28 | Process for the synthesis of dabigatran and its intermediates |
US15/291,087 US10077251B2 (en) | 2012-10-29 | 2016-10-12 | Process for the synthesis of Dabigatran Etexilate and its intermediates |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN4484CH2012 | 2012-10-29 | ||
IN4484/CHE/2012 | 2012-10-29 |
Related Child Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US14/438,995 A-371-Of-International US9533971B2 (en) | 2012-10-29 | 2013-10-28 | Process for the synthesis of dabigatran and its intermediates |
US15/291,087 Division US10077251B2 (en) | 2012-10-29 | 2016-10-12 | Process for the synthesis of Dabigatran Etexilate and its intermediates |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2014068587A2 WO2014068587A2 (fr) | 2014-05-08 |
WO2014068587A3 true WO2014068587A3 (fr) | 2014-07-17 |
Family
ID=50628207
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IN2013/000652 WO2014068587A2 (fr) | 2012-10-29 | 2013-10-28 | Procédé amélioré de synthèse du dabigatran et de ses intermédiaires |
Country Status (2)
Country | Link |
---|---|
US (1) | US9533971B2 (fr) |
WO (1) | WO2014068587A2 (fr) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10077251B2 (en) * | 2012-10-29 | 2018-09-18 | Biophore India Pharmaceuticals Pvt. Ltd. | Process for the synthesis of Dabigatran Etexilate and its intermediates |
CN104744438A (zh) * | 2014-12-17 | 2015-07-01 | 烟台东诚药业集团股份有限公司 | 一种用于合成制备达比加群酯苯并咪唑中间体的方法 |
CN105348263B (zh) * | 2015-12-15 | 2018-03-23 | 乐普药业股份有限公司 | 一种达比加群酯中间体的制备方法 |
CN105906607A (zh) * | 2015-12-23 | 2016-08-31 | 嘉实(湖南)医药科技有限公司 | 一种达比加群酯的合成方法 |
CN107417603B (zh) * | 2017-05-17 | 2020-08-11 | 张家港威胜生物医药有限公司 | 一种克里唑替尼中间体制备方法 |
CN111793058A (zh) * | 2019-04-09 | 2020-10-20 | 鲁南制药集团股份有限公司 | 一种制备达比加群酯中间体的改良方法 |
Citations (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998037075A1 (fr) * | 1997-02-18 | 1998-08-27 | Boehringer Ingelheim Pharma Kg | Heterocycles bicycliques disubstitues, production et utilisation comme medicaments |
WO2000001704A2 (fr) * | 1998-07-04 | 2000-01-13 | Boehringer Ingelheim Pharma Kg | Benzimidazoles, leur preparation et leur utilisation comme medicaments |
DE19962329A1 (de) * | 1999-12-23 | 2001-06-28 | Boehringer Ingelheim Pharma | Benzimidazole, deren Herstellung und deren Verwendung als Arzneimittel |
US20030004356A1 (en) * | 1999-12-23 | 2003-01-02 | Boehringer Ingelheim Pharma Kg | Benzimidazoles with antithrombotic activity |
WO2006000353A1 (fr) * | 2004-06-25 | 2006-01-05 | Boehringer Ingelheim International Gmbh | Procede pour produire des 4-(benzimidazolylmethylamino)-benzamidines |
WO2007071743A1 (fr) * | 2005-12-21 | 2007-06-28 | Boehringer Ingelheim International Gmbh | Procede ameliore pour la preparation de sels de 4-(benzimidazolylmethylamino)-benzamides |
WO2007071742A1 (fr) * | 2005-12-21 | 2007-06-28 | Boehringer Ingelheim International Gmbh | Procede ameliore pour la preparation de 4-(benzimidazolylmethylamino)-benzamides et des sels de ceux-ci |
WO2008095928A1 (fr) * | 2007-02-06 | 2008-08-14 | Boehringer Ingelheim International Gmbh | Procédé de préparation d'un dérivé de benzimidazole |
WO2009111997A1 (fr) * | 2008-03-14 | 2009-09-17 | Zentiva, K.S. | Procédé de préparation de dabigatran |
WO2009153214A1 (fr) * | 2008-06-16 | 2009-12-23 | Boehringer Ingelheim International Gmbh | Procédé de fabrication d'un intermédiaire dans la synthèse du dabigatran |
WO2012004397A1 (fr) * | 2010-07-09 | 2012-01-12 | Esteve Química, S.A. | Intermédiaires et procédé de préparation d'un inhibiteur spécifique de la thrombine |
WO2013111163A2 (fr) * | 2012-01-20 | 2013-08-01 | Cadila Healthcare Limited | Procédé de préparation de dabigatran étéxilate mésylate et polymorphes d'intermédiaires de celui-ci |
-
2013
- 2013-10-28 US US14/438,995 patent/US9533971B2/en active Active
- 2013-10-28 WO PCT/IN2013/000652 patent/WO2014068587A2/fr active Application Filing
Patent Citations (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998037075A1 (fr) * | 1997-02-18 | 1998-08-27 | Boehringer Ingelheim Pharma Kg | Heterocycles bicycliques disubstitues, production et utilisation comme medicaments |
WO2000001704A2 (fr) * | 1998-07-04 | 2000-01-13 | Boehringer Ingelheim Pharma Kg | Benzimidazoles, leur preparation et leur utilisation comme medicaments |
DE19962329A1 (de) * | 1999-12-23 | 2001-06-28 | Boehringer Ingelheim Pharma | Benzimidazole, deren Herstellung und deren Verwendung als Arzneimittel |
US20030004356A1 (en) * | 1999-12-23 | 2003-01-02 | Boehringer Ingelheim Pharma Kg | Benzimidazoles with antithrombotic activity |
WO2006000353A1 (fr) * | 2004-06-25 | 2006-01-05 | Boehringer Ingelheim International Gmbh | Procede pour produire des 4-(benzimidazolylmethylamino)-benzamidines |
WO2007071743A1 (fr) * | 2005-12-21 | 2007-06-28 | Boehringer Ingelheim International Gmbh | Procede ameliore pour la preparation de sels de 4-(benzimidazolylmethylamino)-benzamides |
WO2007071742A1 (fr) * | 2005-12-21 | 2007-06-28 | Boehringer Ingelheim International Gmbh | Procede ameliore pour la preparation de 4-(benzimidazolylmethylamino)-benzamides et des sels de ceux-ci |
WO2008095928A1 (fr) * | 2007-02-06 | 2008-08-14 | Boehringer Ingelheim International Gmbh | Procédé de préparation d'un dérivé de benzimidazole |
WO2009111997A1 (fr) * | 2008-03-14 | 2009-09-17 | Zentiva, K.S. | Procédé de préparation de dabigatran |
WO2009153214A1 (fr) * | 2008-06-16 | 2009-12-23 | Boehringer Ingelheim International Gmbh | Procédé de fabrication d'un intermédiaire dans la synthèse du dabigatran |
WO2012004397A1 (fr) * | 2010-07-09 | 2012-01-12 | Esteve Química, S.A. | Intermédiaires et procédé de préparation d'un inhibiteur spécifique de la thrombine |
WO2013111163A2 (fr) * | 2012-01-20 | 2013-08-01 | Cadila Healthcare Limited | Procédé de préparation de dabigatran étéxilate mésylate et polymorphes d'intermédiaires de celui-ci |
Also Published As
Publication number | Publication date |
---|---|
WO2014068587A2 (fr) | 2014-05-08 |
US9533971B2 (en) | 2017-01-03 |
US20150246900A1 (en) | 2015-09-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SI3683209T1 (sl) | Postopek za pripravo ((5-(3-klorofenil)-3-hidroksipiridin-2-karbonil)-amino)ocetne kisline iz 5-((3-klorofenil)-3-kloro-piridin-2-il)-nitrila in postopek za pripravo derivatov 5-((halofenil)-3-halo-piridin-2-il)-nitrila | |
WO2012077136A3 (fr) | Procédé de préparation de dérivés de benzimidazole et de leurs sels | |
MX2020001602A (es) | Inhibidor del antigeno-1 asociado a la funcion del linfocito (lfa-1) y polimorfo del mismo. | |
HK1200167A1 (zh) | 作為用於治療癌症和免疫性和自身免疫性疾病的凋亡誘導劑的 -氨基甲酰基- -二取代吡啶- -基 -四氫異喹啉衍生物 | |
AP2012006339A0 (en) | Methods of administering pirfenidone therapy. | |
WO2014068587A3 (fr) | Procédé amélioré de synthèse du dabigatran et de ses intermédiaires | |
EP2667714A4 (fr) | Procédé de préparation de 4-amino-5-fluoro-3-halogéno-6-(substitué)picolinates | |
IL230635A (en) | An outgrowth of 4,3,2,1-tetrahydroquinoline used to treat diabetes | |
ZA201305582B (en) | Process for the preparation of 4-amino-5-fluoro-3-halo-6-(sunstituted)picolinates | |
ZA201100044B (en) | Improved process for the preparation of 2-trifluoromethyl-5-(1-substituted)alkylpyridines | |
WO2014192030A3 (fr) | Procédé amélioré pour la préparation de l'étéxilate de dabigatran et sels d'addition acide pharmaceutiquement acceptables de celui-ci | |
EP2668163A4 (fr) | Procédé de préparation de 4-amino-3-chloro-5-fluoro-6-picolinates (substitués) | |
HK1206938A1 (en) | Process for the preparation of 3-chloro-4,5,6-trifluoro- picolinonitrile 3--456-- | |
WO2014141292A3 (fr) | Polymorphe de citrate d'endoxifène et son procédé de préparation | |
WO2014049585A3 (fr) | Procédé de préparation d'étéxilate de dabigatran ou d'un sel pharmaceutiquement acceptable de cette substance | |
ZA201207397B (en) | Process for the preparation of dexlansoprazole | |
EP2709455A4 (fr) | Procédés de préparation de l'acide 5-azaspiro[2.4]heptane-6-carboxylique et de ses dérivés | |
WO2014167577A3 (fr) | Synthèse du dabigatran | |
WO2010148314A3 (fr) | Préparation d'ésoméprazole et de ses sels pharmaceutiquement acceptables | |
ZA201303872B (en) | Improved process for the preparation of 2-trifluoromethyl-5-(1-substituted)alkylpyridines | |
PL399613A1 (pl) | Pochodne estrów diarylowych kwasów 1-aminoalkanofosfonowych, sposób wytwarzania pochodnych estrów diarylowych kwasów 1-aminoalkanofosfonowych oraz ich zastosowanie | |
ZA201309732B (en) | Process for the preparation of dexlansoprazole | |
WO2014020546A3 (fr) | Formes cristallines d'étexilate de dabigatran et leur procédé de préparation | |
PL2734492T3 (pl) | Sposób wytwarzania 1,1,1-trifluoropropanu | |
PL396024A1 (pl) | Sposób wytwarzania 4,2',4' -trihydroksy-6'-metoksy-3'-prenylo-α,ß-dihydrochalkonu |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 14438995 Country of ref document: US |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 13850539 Country of ref document: EP Kind code of ref document: A2 |